Basket

  Untick selected:   0
  1. Postoperative adjuvant lapatinib and concurrent chemoradiotherapy followed by maintenance lapatinib monotherapy in high-risk patients with resected squamous cell carcinoma of the head and neck: A Phase III, randomized, double-blind, placebo-controlled study.  / Harrington K., Dubinsky P. ... [et al.] .  Onkológia. - ISSN 1336-8176 . - Roč. 10, č. 6 (2015), s. 403  
    C 3069
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.